Integrase inhibitor gains FDA approval.
Traynor
Kate
K
D004279:DNA, Viral / Q000187:drug effects; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000592:standards* / Q000627:therapeutic use; D015497:HIV-1 / Q000201:enzymology; D006801:Humans; D009930:Organic Chemicals / Q000592:standards* / Q000627:therapeutic use; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014481:United States; D014486:United States Food and Drug Administration
D004279:DNA, Viral; D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium